Skip to main content
Premium Trial:

Request an Annual Quote

Aria Biosystems Raises $5.5M In First Round of VC Funding

NEW YORK, June 15 (GenomeWeb News) - Aria Biosystems, a biomolecular sensor startup, has raised $5.5 million in an initial round of venture capital financing, the company said today.

 

The Menlo Park, Calif. company said it will use the proceeds of this initial round to complete development of a first product and to further development of subsequent products.

 

Aria's technology is based on fiber optics and adopted from the telecommunications industry. The disposable sensors are self-calibrating, and can can measure concentrations of analytes and binding kinetics in real time, without labeling, according to the company.

 

Alloy Ventures and Latterell Venture Partners co-led the round, and were joined by Agilent Ventures and Versant Ventures.

 

In conjunction with the financing, Aria announced that Craig Taylor, general partner of Alloy Ventures, James Woody, a venture partner of Latterell Venture Partners; and Deborah Neff, President and CEO of Predicant Biosciences, would be joining the company's board, along with Winnie   Wan, the company's CEO and co-founder.

 

Other founding executives of Aria include Hong Tan, president and chief technical officer, Dave Hoyt, chief financial officer, and Bob Zuk, vice president of development.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.